Premium
Complete metabolic response following anaplastic lymphoma kinase ( ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results
Author(s) -
Chazan Grace,
Forbes Danielle,
Murugasu Anand,
Wong HuiLi,
Solomon Benjamin
Publication year - 2021
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.15450
Subject(s) - medicine , anaplastic lymphoma kinase , oncology , gynecologic oncology , lung cancer , malignant pleural effusion